The effect of dexamethasone on post-tonsillectomy nausea, vomiting and bleeding

Area of Science:

• Pediatric Anesthesiology
• Surgical Outcomes Research

Background:

• Dexamethasone is sometimes administered to reduce morbidity after tonsillectomy.
• Its actual impact on key post-operative outcomes requires further evaluation.

Purpose of the Study:

• To re-evaluate Dexamethasone blood values at fixed doses.
• To assess Dexamethasone's effect on post-tonsillectomy nausea, vomiting, and bleeding.

Main Methods:

• Retrospective cohort study of 272 children (ages 2-15) undergoing tonsillectomy.
• Analyzed post-operative nausea, vomiting, and bleeding rates in relation to Dexamethasone administration and dosage.
• Compared outcomes between children who received Dexamethasone and those who did not, and across different dose groups.

Main Results:

• Dexamethasone was given to 43.7% of patients (mean dose 0.2 mg/kg).
• No significant differences in nausea, vomiting (p=0.953), or bleeding (p=0.827) were observed between Dexamethasone and non-Dexamethasone groups.
• No dose-related risk for these outcomes was identified (p=0.98 for nausea/vomiting, p=0.71 for bleeding).

Conclusions:

• Under typical clinical conditions, Dexamethasone does not appear to influence nausea, vomiting, or bleeding rates following tonsillectomy.
• The findings suggest current non-controlled Dexamethasone use may not alter these specific post-operative morbidities.